People Transfer

Premium

Sherrill Neff, founding partner of venture capital firm Quaker BioVentures, has been named to the board of directors of the National Venture Capital Association.

Neff founded Quaker BioVentures with Brenda Gavin and Ira Lubert in 2002. Prior to that, he was president and chief operating officer of Neose Technologies, senior vice president of corporate development at US Healthcare, and managing director in the investment banking division of Alex Brown & Sons. He also worked as a corporate attorney at Morgan, Lewis & Bockius.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.